Jinzi Jason Wu, Ascletis Pharma CEO
Ascletis’ obesity pill looks similar to Roche’s drug, early data suggest
Ascletis Pharma’s oral GLP-1 allowed patients in an early-stage obesity trial to lose up to 6.3% of their body weight after a month of treatment …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
